Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Ph phase_2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Detailed Status

Completed1

Not yet recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

completed133%

not_yet_recruiting133%

withdrawn133%

Recent Activity

0 active trials

Showing 3 of 3

withdrawnphase_2

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

NCT07484906

not_yet_recruitingnot_applicable

Neurofeedback Removal of Emotional Information From Mind

NCT06460207

completednot_applicable

Physiological Regulation of Chronic Tinnitus

NCT05737888

Clinical Trials (3)

Showing 3 of 3 trials

NCT07484906Phase 2

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Withdrawn

NCT06460207Not Applicable

Neurofeedback Removal of Emotional Information From Mind

Not Yet Recruiting

NCT05737888Not Applicable

Physiological Regulation of Chronic Tinnitus

Completed

All 3 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 3